Granulocyte colony-stimulating factor (G-CSF) has been proposed in neutropenic (granulocyte absolute count < 1500/μL) neonates to reduce the risk of infectious complications, but its administration had no significant effect on infection-free and overall survival [49]. This evidence concerns the gene CSF3 and infection.